Diagnostic Electrocardiograph ECG Market - Global Forecast to 2032
商品番号 : SMB-42296
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 374 |
| 図表数 | 416 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、診断用ECG市場を製品、リードタイプ、種類、導入／接続性、エンドユーザー、地域の観点から分析しています。また、市場成長に影響を与える要因（推進要因、制約要因、機会、課題など）を分析するとともに、市場リーダー企業の競争環境の詳細も提供しています。さらに、マイクロマーケットを個々の成長傾向に基づいて分析し、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
The global diagnostic electrocardiograph/ECG market is projected to reach USD 15.18 billion by 2032 from USD 9.19 billion in 2025, at a CAGR of 7.4% during the forecast period.
世界の診断用心電計/ECG市場は、予測期間中に7.4%のCAGRで成長し、2025年の91億9,000万米ドルから2032年には151億8,000万米ドルに達すると予測されています。
The significant expansion of the geriatric demographic worldwide, coupled with the escalating prevalence of chronic conditions such as diabetes and CVDs, is poised to drive the demand for the diagnostic ECG market. Additionally, the increasing focus on preventive healthcare, coupled with rising healthcare expenditures and improvements in healthcare infrastructure across various regions, also facilitates market growth. Technological advancements in diagnostic ECG devices, the introduction of innovative products, and favorable reimbursement frameworks, along with supportive government policies, are further expected to enhance market dynamics. Investments in healthcare infrastructure and initiatives to improve the accessibility and affordability of diagnostic ECG solutions are also likely to bolster market progression.
世界中で高齢者人口が大幅に増加し、糖尿病やCVDといった慢性疾患の罹患率も増加していることから、診断用ECG市場の需要は今後さらに高まると予想されます。さらに、予防医療への関心の高まり、医療費の増加、そして様々な地域における医療インフラの改善も市場の成長を後押ししています。診断用ECG機器の技術的進歩、革新的な製品の導入、そして有利な償還制度、そして政府の支援政策は、市場のダイナミクスをさらに強化すると期待されます。医療インフラへの投資や、診断用ECGソリューションのアクセス性と価格向上に向けた取り組みも、市場の発展を後押しすると考えられます。
The diagnostic ECG devices segment is to grow at the highest CAGR during the forecast period.
The diagnostic ECG market is predominantly driven by devices, which command the largest market share in 2024. This surge is primarily attributed to the rising incidence of CVDs, including coronary artery disease, stroke, and peripheral artery disease. Furthermore, the demand for early and continuous cardiac monitoring among geriatric populations, along with the increasing trend toward remote patient management, significantly underpins this growth trajectory. Recent advancements in device technology, such as miniaturization and enhanced wireless connectivity, are rendering these instruments more efficient, user-centric, and accessible. This evolution enables the provision of cardiac care in both conventional clinical environments and remote settings, thereby improving patient outcomes and optimizing healthcare delivery.
The 12-lead ECG devices segment captured the largest market share, by lead type, in 2024.
Based on lead type, the diagnostic ECG market is segmented into 12, 5, 3, 6, and single lead ECG devices. The 12-lead ECG systems dominate the market due to their ability to deliver comprehensive analysis and a multi-faceted view of cardiac electrical activity through twelve electrode placements—this capability facilitates accurate diagnosis of a range of CVDs, including myocardial infarctions, complex arrhythmias, and ischemic heart disease. Clinicians, particularly in emergency departments, ICUs, and specialized cardiology clinics, heavily depend on the rich data provided by 12-lead ECGs for critical clinical decision-making and timely therapeutic interventions. Furthermore, recent technological advancements, such as portable digital 12-lead ECG devices featuring wireless connectivity and seamless integration with telemedicine platforms, have further solidified the essential role of these systems in the landscape of diagnostic ECG.
The standalone ECG devices segment commanded the largest market share, by deployment/connectivity in 2024.
Based on deployment/ connectivity, the diagnostic ECG market is segmented into standalone, PC-based, and cloud-based ECG devices. Standalone ECG devices accounted for the market share, driven by the rising global prevalence of CVDs that necessitate more accessible and continuous monitoring. The technological advancements have led to the development of compact, precise, and user-friendly devices, coupled with an increasing focus on remote patient monitoring and home-based care. This trend also enhances preventive health management and facilitates self-monitoring of cardiac health outside traditional clinical environments. These devices are instrumental in the early detection of arrhythmias and other cardiac conditions, thus reducing the frequency of hospital visits. They serve as cost-effective alternatives for proactive cardiac health management and can be seamlessly integrated with telemedicine platforms and artificial intelligence for enhanced diagnostic capabilities.
North America accounted for the largest regional share of the diagnostic ECG market in 2024.
The global diagnostic ECG market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for diagnostic ECG, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
The significant predominance of the North American market can largely be attributed to several interrelated factors. Firstly, there is a rising incidence of CVDs, which has become a pressing public health concern and is driving demand for related healthcare services and products. This increase is further supported by a robust and well-established healthcare infrastructure that efficiently provides medical care and resources to address these health challenges. Additionally, the population in North America enjoys elevated disposable incomes, which allows individuals to prioritize spending on health-related investments, including preventive care and advanced treatment options. This financial capability also supports the adoption of innovative medical technologies and solutions, which are widely accessible throughout the region. The extensive availability of cutting-edge technological advancements in healthcare, including diagnostic tools, treatment modalities, and patient management systems, enhances the overall quality of care and improves health outcomes for patients with CVDs. Together, these factors create a strong environment for market growth and the ongoing evolution of healthcare solutions in North America. Furthermore, the influence of leading industry players such as GE Healthcare, Baxter, and OSI Systems, Inc. is expected to catalyze growth in the diagnostic ECG market within the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3– 25%
- By Designation: C-level–30%, Director-level–23%, and Other Designations–47%
- By Region: North America–35%, Europe–20%, Asia Pacific–25%, Latin America–13%, and Middle East & Africa–7%
The major players operating in the diagnostic ECG market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Baxter (US), FUKUDA DENSHI (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), NIHON KOHDEN CORPORATION (Japan), OSI Systems, Inc. (US), Bittium (Finland), iRhythm Technologies, Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), Midmark Corporation (US), BPL Medical Technologies (India), SCHILLER (Switzerland), ACS Diagnostics (US), Allengers (India), and Bionet Co., Ltd. (South Korea).
Research Coverage
This report studies the diagnostic ECG market based on product, lead type, type, deployment/ connectivity, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.
This report provides insights on the following points:
Analysis of Key divers (increasing incidence of lifestyle and cardiovascular diseases, expanding global geriatric population and subsequent surge in heart conditions, development of wireless monitoring and wearable cardiac devices, and growing need for cost-containment across healthcare facilities), restraints (stringent regulatory requirements delaying cardiac device approval and technological limitations of diagnostic ECG devices & software), Opportunities (High growth opportunities in emerging economies and expanding access to advanced cardiac diagnostics with AI and CMS support), Challenges (Limited integration of ECG Systems with electronic health records and accuracy challenges in next-generation ECG monitoring)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic ECG market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic ECG market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic ECG market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
2.1.2.1 Primary sources 38
2.1.2.2 Key industry insights 39
2.1.2.3 Breakdown of primaries 39
2.2 MARKET SIZE ESTIMATION OF DIAGNOSTIC ECG PRODUCTS 40
2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 41
2.2.2 MNM REPOSITORY ANALYSIS 42
2.2.3 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS 42
2.2.4 TOP-DOWN APPROACH 42
2.2.5 BOTTOM-UP APPROACH 43
2.2.6 PRIMARY INTERVIEWS 43
2.2.7 DEMAND-SIDE APPROACH 43
2.2.8 VOLUME DATA ANALYSIS 44
2.3 MARKET GROWTH RATE PROJECTION 44
2.4 DATA TRIANGULATION 45
2.4.1 STUDY ASSUMPTIONS 46
2.4.2 RESEARCH LIMITATIONS 46
2.5 RISK ANALYSIS 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 52
4.1 DIAGNOSTIC ECG MARKET OVERVIEW 52
4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY TYPE AND COUNTRY (2024) 53
4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY DEVICE TYPE, 2025 VS. 2032 53
4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION) 54
4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION) 55
4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases 58
5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions 58
5.2.1.3 Development of wireless monitoring and wearable cardiac devices 59
5.2.1.4 Growing need for cost-containment across healthcare facilities 59
5.2.2 RESTRAINTS 60
5.2.2.1 Stringent regulatory requirements delaying approval of
cardiac devices 60
5.2.2.2 Technological limitations of diagnostic ECG devices and software 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Emerging markets to offer high-growth opportunities 61
5.2.3.2 Expanding access to advanced cardiac diagnostics with
AI and CMS support 62
5.2.4 CHALLENGES 62
5.2.4.1 Challenges in integrating ECG systems with Electronic
Health Records (EHRs) 62
5.2.4.2 Accuracy challenges in next-generation ECG monitoring 63
5.3 INDUSTRY TRENDS 63
5.3.1 MINIATURIZATION AND WEARABLE ECG DEVICES 63
5.3.2 REMOTE AND HOME-BASED DIAGNOSTICS 64
5.3.3 HIGH-FIDELITY AND MULTI-LEAD PORTABLE ECGS 64
5.4 TECHNOLOGY ANALYSIS 64
5.4.1 KEY TECHNOLOGIES 64
5.4.1.1 Wearable devices and sensors 64
5.4.1.2 Integration of Artificial Intelligence (AI) 65
5.4.2 COMPLEMENTARY TECHNOLOGIES 65
5.4.2.1 Wireless ECG devices 65
5.4.2.2 Mobile apps integration 66
5.4.3 ADJACENT TECHNOLOGIES 66
5.4.3.1 Vital sign monitors 66
5.5 PORTER’S FIVE FORCES ANALYSIS 67
5.5.1 THREAT OF NEW ENTRANTS 68
5.5.2 THREAT OF SUBSTITUTES 68
5.5.3 BARGAINING POWER OF BUYERS 68
5.5.4 BARGAINING POWER OF SUPPLIERS 68
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.6 REGULATORY LANDSCAPE 68
5.6.1 REGULATORY ANALYSIS 68
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
5.6.3 REGULATORY FRAMEWORK 70
5.6.3.1 North America 70
5.6.3.1.1 US 70
5.6.3.1.2 Canada 70
5.6.3.2 Europe 71
5.6.3.3 Asia Pacific 71
5.6.3.3.1 China 71
5.6.3.3.2 Japan 71
5.6.3.3.3 India 71
5.6.3.4 Latin America 72
5.6.3.4.1 Brazil 72
5.6.3.4.2 Mexico 72
5.6.3.5 Middle East 72
5.6.3.6 Africa 73
5.7 PATENT ANALYSIS 73
5.7.1 PATENT PUBLICATION TRENDS FOR DIAGNOSTIC ECG 73
5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS 74
5.8 TRADE ANALYSIS 76
5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS 76
5.8.2 TRADE DATA FOR HS CODE 901811 76
5.8.2.1 Import data for HS Code 901811 76
5.8.2.2 Export data for HS Code 901811 77
5.9 PRICING ANALYSIS 77
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 77
5.9.1.1 Average selling price of resting ECG, by key player 78
5.9.1.2 Average selling price for stress ECG, by key player 78
5.9.1.3 Average selling price of Holter monitors, by key player 79
5.9.2 AVERAGE SELLING PRICE, BY REGION 79
5.9.2.1 Average selling price of resting ECG, stress ECG, and
Holter monitors, by region 79
5.10 REIMBURSEMENT SCENARIO 80
5.11 KEY CONFERENCES & EVENTS, 2025–2026 81
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
5.12.2 KEY BUYING CRITERIA 83
5.13 UNMET NEEDS/END-USER EXPECTATIONS 84
5.14 VALUE CHAIN ANALYSIS 85
5.15 SUPPLY CHAIN ANALYSIS 87
5.16 ECOSYSTEM ANALYSIS 88
5.17 IMPACT OF AI/GEN AI ON DIAGNOSTIC ECG MARKET 90
5.17.1 INTRODUCTION 90
5.17.2 MARKET POTENTIAL IN DIAGNOSTIC ECG ECOSYSTEM 90
5.17.3 AI USE CASES 91
5.17.4 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES 91
5.17.5 FUTURE OF GEN AI IN DIAGNOSTIC ECG ECOSYSTEM 92
5.18 CASE STUDY ANALYSIS 93
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.20 IMPACT OF 2025 US TARIFF 95
5.20.1 INTRODUCTION 95
5.20.2 KEY TARIFF RATES 96
5.20.3 PRICE IMPACT ANALYSIS 97
5.20.4 IMPACT ON COUNTRY/REGION 97
5.20.5 IMPACT ON END-USER INDUSTRIES 100
5.21 INVESTMENT AND FUNDING SCENARIO 101
6 DIAGNOSTIC ECG MARKET, BY PRODUCT 103
6.1 INTRODUCTION 104
6.2 DEVICES 104
6.2.1 RESTING ECG DEVICES 106
6.2.1.1 Wide availability of resting ECG devices to support market growth 106
6.2.2 STRESS ECG DEVICES 109
6.2.2.1 High cost of stress ECG devices to limit adoption 109
6.2.3 HOLTER MONITORS 111
6.2.3.1 Growing demand for continuous monitoring to fuel growth 111
6.2.4 EVENT MONITORS 113
6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth 113
6.2.5 IMPLANTABLE LOOP RECORDERS 115
6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth 115
6.2.6 MOBILE CARDIAC TELEMETRY DEVICES 117
6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market 117
6.2.7 SMART ECG MONITORS 119
6.2.7.1 Rising adoption of smart/wearable ECG monitors 119
6.3 SOFTWARE & SERVICES 121
6.3.1 SHIFT TOWARD AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH 121
7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE 123
7.1 INTRODUCTION 124
7.2 12-LEAD ECG DEVICES 124
7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO
DRIVE MARKET GROWTH 124
7.3 5-LEAD ECG DEVICES 127
7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION 127
7.4 3-LEAD ECG DEVICES 129
7.4.1 VITAL TOOL FOR RHYTHM MONITORING TO SUPPORT MARKET GROWTH 129
7.5 6-LEAD ECG DEVICES 131
7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH 131
7.6 SINGLE-LEAD ECG DEVICES 133
7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES 133
7.7 OTHER ECG LEAD DEVICES 135
8 DIAGNOSTIC ECG MARKET, BY TYPE 136
8.1 INTRODUCTION 137
8.2 PORTABLE 138
8.2.1 CONVENIENCE AND ACCESSIBILITY OF PORTABLE ECG DEVICES TO ENHANCE EARLY CARDIAC SCREENING 138
8.3 WEARABLE 140
8.3.1 RISING DEMAND FOR CONTINUOUS HEART MONITORING IN FITNESS AND CHRONIC DISEASE MANAGEMENT 140
8.4 IMPLANTABLE 142
8.4.1 HIGH DIAGNOSTIC YIELD FOR ELUSIVE CARDIAC CONDITIONS WITH
LONG-TERM MONITORING 142
9 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY 144
9.1 INTRODUCTION 145
9.2 STANDALONE ECG DEVICES 145
9.2.1 WIDESPREAD ADOPTION OF STANDALONE ECG DEVICES DUE TO OPERATIONAL SIMPLICITY 145
9.3 PC-BASED ECG DEVICES 147
9.3.1 GROWING USE FOR ADVANCED ECG DIAGNOSTICS AND INTEGRATION TO SUPPORT REMOTE CARDIAC CARE 147
9.4 CLOUD-BASED ECG DEVICES 149
9.4.1 ACCELERATED GROWTH OF CLOUD-BASED ECG SOLUTIONS TO SUPPORT REMOTE CARDIAC CARE 149
10 DIAGNOSTIC ECG MARKET, BY END USER 151
10.1 INTRODUCTION 152
10.2 HOSPITALS 152
10.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS TO
ACCELERATE MARKET GROWTH 152
10.3 PRIMARY CARE CENTERS 154
10.3.1 WIDENING ACCESS TO ECG DIAGNOSTICS IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION 154
10.4 CARDIAC CENTERS 156
10.4.1 SPECIALIZED ECG APPLICATIONS IN CARDIAC CENTERS TO DRIVE DEMAND FOR ADVANCED DEVICES 156
10.5 AMBULATORY SURGICAL CENTERS 158
10.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN ASCS TO INFLUENCE MARKET DEMAND 158
10.6 HOME CARE SETTINGS 160
10.6.1 RISING PREFERENCE FOR REMOTE MONITORING FUELS ECG DEVICE USAGE IN HOME CARE 160
10.7 URGENT CARE SETTINGS 162
10.7.1 INTEGRATION OF DIAGNOSTIC ECG IN URGENT CARE SETTINGS FOR TIMELY CARDIAC EVALUATIONS TO FUEL MARKET DEMAND 162
10.8 OTHER END USERS 164
10.8.1 DIVERSE ECG APPLICATIONS ACROSS NURSING HOMES, RETAIL CLINICS, SPORTS MEDICINE & RESEARCH TO INFLUENCE MARKET DEMAND 164
11 DIAGNOSTIC ECG MARKET, BY REGION 166
11.1 INTRODUCTION 167
11.2 NORTH AMERICA 168
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 168
11.2.2 US 173
11.2.2.1 US to command largest share in diagnostic ECG market 173
11.2.3 CANADA 177
11.2.3.1 Growing adoption of digital diagnostic ECG systems to drive
market growth 177
11.3 EUROPE 180
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 180
11.3.2 GERMANY 184
11.3.2.1 High healthcare spending to propel market growth 184
11.3.3 FRANCE 188
11.3.3.1 Government support for e-Health to propel market 188
11.3.4 UK 191
11.3.4.1 Rising demand for home-based smart ECG devices to support
market growth 191
11.3.5 ITALY 194
11.3.5.1 Growing focus on improvements in patient care to drive market 194
11.3.6 SPAIN 198
11.3.6.1 Rising geriatric population to support market growth in Spain 198
11.3.7 REST OF EUROPE 201
11.4 ASIA PACIFIC 204
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 205
11.4.2 JAPAN 210
11.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 210
11.4.3 CHINA 214
11.4.3.1 Government support for infrastructural improvement to drive
market growth 214
11.4.4 INDIA 218
11.4.4.1 Increasing cardiac disease burden intensifies demand for
ECG diagnostics 218
11.4.5 AUSTRALIA 221
11.4.5.1 Increased patient volume and favorable government initiatives to drive market 221
11.4.6 SOUTH KOREA 224
11.4.6.1 Rising geriatric population to propel market growth 224
11.4.7 MALAYSIA 227
11.4.7.1 Increasing CVD burden and national digital health initiatives driving ECG adoption 227
11.4.8 THAILAND 230
11.4.8.1 National cardiac screening programs and smart hospital investments driving ECG adoption in Thailand 230
11.4.9 INDONESIA 233
11.4.9.1 Rising cardiac disease burden and public health digitalization efforts to drive ECG device uptake in Indonesia 233
11.4.10 REST OF ASIA PACIFIC 236
11.5 LATIN AMERICA 239
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240
11.5.2 BRAZIL 243
11.5.2.1 Improving access to diagnostic services to drive growth 243
11.5.3 MEXICO 246
11.5.3.1 Rising heart disease to drive market growth 246
11.5.4 REST OF LATIN AMERICA 249
11.6 MIDDLE EAST & AFRICA 252
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 252
11.6.2 GCC COUNTRIES 256
11.6.2.1 Kingdom of Saudi Arabia (KSA) 260
11.6.2.1.1 Prevalence of CVDs boosting ECG adoption in Saudi Arabia 260
11.6.2.2 United Arab Emirates (UAE) 264
11.6.2.2.1 National CVD screening programs and digital health strategies driving market 264
11.6.2.3 Rest of GCC Countries 267
11.6.3 REST OF MIDDLE EAST & AFRICA 270
12 COMPETITIVE LANDSCAPE 274
12.1 INTRODUCTION 274
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 274
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
DIAGNOSTIC ECG MARKET 274
12.3 REVENUE SHARE ANALYSIS (2022-2024) 276
12.4 MARKET SHARE ANALYSIS, 2024 277
12.4.1 RANKING OF KEY PLAYERS 280
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 280
12.5.1 STARS 280
12.5.2 EMERGING LEADERS 280
12.5.3 PERVASIVE PLAYERS 281
12.5.4 PARTICIPANTS 281
12.5.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024 282
12.5.5.1 Company footprint 282
12.5.5.2 Region footprint 283
12.5.5.3 Product footprint 284
12.5.5.4 Lead type footprint 285
12.5.5.5 Type footprint 286
12.5.5.6 Deployment/Connectivity footprint 287
12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024 287
12.6.1 PROGRESSIVE COMPANIES 287
12.6.2 RESPONSIVE COMPANIES 288
12.6.3 DYNAMIC COMPANIES 288
12.6.4 STARTING BLOCKS 288
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 289
12.6.5.1 Detailed list of key startups/SME players 289
12.6.5.2 Competitive benchmarking of key startups/SME players 290
12.7 BRAND/PRODUCT COMPARISON 291
12.8 DIAGNOSTIC ECG MARKET: COMPANY VALUATION & FINANCIAL METRICS 292
12.8.1 FINANCIAL METRICS 292
12.8.2 COMPANY VALUATION 292
12.9 COMPETITIVE SCENARIO 293
12.9.1 PRODUCT LAUNCHES & APPROVALS 293
12.9.2 DEALS 295
12.9.3 EXPANSIONS 297
12.9.4 OTHER DEVELOPMENTS 298
13 COMPANY PROFILES 300
13.1 KEY PLAYERS 300
13.1.1 KONINKLIJKE PHILIPS N.V. 300
13.1.1.1 Business overview 300
13.1.1.2 Products/Services/Solutions offered 301
13.1.1.3 Recent developments 303
13.1.1.3.1 Product/Service launches 303
13.1.1.3.2 Deals 304
13.1.1.3.3 Other developments 304
13.1.1.4 MnM view 304
13.1.1.4.1 Key strengths/Right to win 304
13.1.1.4.2 Strategic choices 305
13.1.1.4.3 Weaknesses and competitive threats 305
13.1.2 GE HEALTHCARE 306
13.1.2.1 Business overview 306
13.1.2.2 Products offered 307
13.1.2.3 Recent developments 308
13.1.2.3.1 Deals 308
13.1.2.3.2 Other developments 309
13.1.2.4 MnM view 309
13.1.2.4.1 Key strengths/Right to win 309
13.1.2.4.2 Strategic choice 310
13.1.2.4.3 Weaknesses and competitive threats 310
13.1.3 MEDTRONIC 311
13.1.3.1 Business overview 311
13.1.3.2 Products offered 312
13.1.3.3 MnM view 313
13.1.3.3.1 Right to win 313
13.1.3.3.2 Strategic choices 313
13.1.3.3.3 Weaknesses and competitive threats 313
13.1.4 BOSTON SCIENTIFIC CORPORATION 314
13.1.4.1 Business overview 314
13.1.4.2 Products offered 316
13.1.4.3 MnM view 316
13.1.4.3.1 Right to win 316
13.1.4.3.2 Strategic choices 316
13.1.4.3.3 Weaknesses and competitive threats 316
13.1.5 ABBOTT LABORATORIES 317
13.1.5.1 Business overview 317
13.1.5.2 Products offered 318
13.1.5.3 Recent developments 319
13.1.5.3.1 Product launches 319
13.1.5.4 MnM view 319
13.1.5.4.1 Key strengths 319
13.1.5.4.2 Strategic choices 319
13.1.5.4.3 Weaknesses & competitive threats 319
13.1.6 BAXTER (HILL-ROM HOLDINGS, INC.) 320
13.1.6.1 Business overview 320
13.1.6.2 Products offered 321
13.1.6.3 MnM view 323
13.1.6.3.1 Key strengths/Right to win 323
13.1.6.3.2 Strategic choices 323
13.1.6.3.3 Weaknesses & competitive threats 324
13.1.7 FUKUDA DENSHI 325
13.1.7.1 Business overview 325
13.1.7.2 Products offered 326
13.1.7.3 MnM view 327
13.1.7.3.1 Key strengths 327
13.1.7.3.2 Strategic choices 327
13.1.7.3.3 Weaknesses & competitive threats 327
13.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 328
13.1.8.1 Business overview 328
13.1.8.2 Products offered 329
13.1.8.3 MnM view 330
13.1.8.3.1 Key strengths 330
13.1.8.3.2 Strategic choices 330
13.1.8.3.3 Weaknesses & competitive threats 330
13.1.9 NIHON KOHDEN CORPORATION 331
13.1.9.1 Business overview 331
13.1.9.2 Products offered 332
13.1.10 OSI SYSTEMS, INC. 334
13.1.10.1 Business overview 334
13.1.10.2 Products offered 335
13.1.10.3 Recent developments 336
13.1.10.3.1 Expansions 336
13.1.11 BITTIUM 337
13.1.11.1 Business overview 337
13.1.11.2 Products offered 338
13.1.11.3 Recent developments 339
13.1.11.3.1 Deals 339
13.1.12 IRHYTHM TECHNOLOGIES, INC. 340
13.1.12.1 Business overview 340
13.1.12.2 Products offered 341
13.1.12.3 Recent developments 341
13.1.12.3.1 Product launches and approvals 341
13.1.12.3.2 Deals 342
13.1.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 343
13.1.13.1 Business overview 343
13.1.13.2 Products offered 344
13.1.13.3 Recent developments 345
13.1.13.3.1 Product launches and approvals 345
13.1.13.3.2 Other developments 346
13.1.14 MIDMARK CORPORATION 347
13.1.14.1 Business overview 347
13.1.14.2 Products offered 347
13.1.14.3 Recent developments 348
13.1.14.3.1 Product launches 348
13.1.15 BPL MEDICAL TECHNOLOGIES 349
13.1.15.1 Business overview 349
13.1.15.2 Products offered 349
13.1.15.3 Recent developments 350
13.1.15.3.1 Expansions 350
13.1.15.3.2 Other developments 351
13.1.16 SCHILLER 352
13.1.16.1 Business overview 352
13.1.16.2 Products offered 352
13.1.16.3 Recent developments 353
13.1.16.3.1 Product launches 353
13.1.16.3.2 Other developments 353
13.1.17 ACS DIAGNOSTICS 354
13.1.17.1 Business overview 354
13.1.17.2 Products offered 354
13.1.18 ALLENGERS 355
13.1.18.1 Business overview 355
13.1.18.2 Products offered 355
13.1.19 BIONET CO., LTD. 356
13.1.19.1 Business overview 356
13.1.19.2 Products offered 356
13.1.19.3 Recent developments 357
13.1.19.3.1 Other developments 357
13.2 OTHER PLAYERS 358
13.2.1 EDAN INSTRUMENTS, INC. 358
13.2.2 QINGDAO MEDITECH EQUIPMENT CO., LTD. 359
13.2.3 CARDIAC INSIGHT, INC. 360
13.2.4 ALIVECOR, INC. 360
13.2.5 VITALCONNECT 361
13.2.6 BTL 362
13.2.7 BORSAM MEDICAL 363
13.2.8 NASIFF ASSOCIATES, INC. 363
13.2.9 VECTRACOR, INC. 364
13.2.10 BIOMEDICAL INSTRUMENTS CO., LTD. 364
13.2.11 LIFESIGNALS 365
14 APPENDIX 366
14.1 DISCUSSION GUIDE 366
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370
14.3 CUSTOMIZATION OPTIONS 372
14.4 RELATED REPORTS 372
14.5 AUTHOR DETAILS 373
LIST OF TABLES
TABLE 1 DIAGNOSTIC ECG MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 33
TABLE 3 DIAGNOSTIC ECG MARKET: STUDY ASSUMPTIONS 46
TABLE 4 DIAGNOSTIC ECG MARKET: RISK ANALYSIS 47
TABLE 5 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 67
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 11 DIAGNOSTIC ECG MARKET: INNOVATIONS AND PATENT REGISTRATIONS,
2023–2025 75
TABLE 12 IMPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021–2024 (USD THOUSAND) 76
TABLE 13 EXPORT DATA FOR HS CODE 901811 (ELECTRO-CARDIOGRAPHS), BY COUNTRY, 2021–2024 (USD THOUSAND) 77
TABLE 14 AVERAGE SELLING PRICE TREND OF RESTING ECG, BY REGION, 2022–2024 80
TABLE 15 AVERAGE SELLING PRICE TREND OF STRESS ECG, BY REGION, 2022–2024 80
TABLE 16 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION, 2022–2024 80
TABLE 17 COMMON CPT CODES AND AVERAGE REIMBURSEMENT RATES 81
TABLE 18 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS 81
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 83
TABLE 20 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 83
TABLE 21 DIAGNOSTIC ECG MARKET: CURRENT UNMET NEEDS 84
TABLE 22 DIAGNOSTIC ECG PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM 89
TABLE 23 KEY COMPANIES IMPLEMENTING AI IN DIAGNOSTIC ECG DEVICES 92
TABLE 24 CASE STUDY 1: ARRHYTHMIA DETECTION IN SINGLE-LEAD ECG CHEST STRAP 93
TABLE 25 CASE STUDY 2: CARDIOSOFT ECG – BICESTER HEALTH CENTRE 93
TABLE 26 CASE STUDY 3: ENHANCING POST-STROKE ATRIAL FIBRILLATION DETECTION
WITH PHILIPS BIOTEL HEART MCOT 94
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES 96
TABLE 28 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR DIAGNOSTIC ELECTROCARDIOGRAPHS 96
TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 97
TABLE 30 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 98
TABLE 31 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 99
TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 100
TABLE 33 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 104
TABLE 34 KEY PLAYERS PROVIDING DIAGNOSTIC ECG DEVICES 105
TABLE 35 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2023–2032 (USD MILLION) 106
TABLE 36 KEY PLAYERS PROVIDING RESTING ECG DEVICES 107
TABLE 37 RESTING ECG DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 108
TABLE 38 KEY PLAYERS PROVIDING STRESS ECG DEVICES 109
TABLE 39 STRESS ECG DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 110
TABLE 40 KEY PLAYERS PROVIDING HOLTER MONITORS 111
TABLE 41 HOLTER MONITORS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 112
TABLE 42 KEY PLAYERS PROVIDING EVENT MONITORS 113
TABLE 43 EVENT MONITORS MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 114
TABLE 44 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 116
TABLE 45 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 118
TABLE 46 SMART ECG MONITORS MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 120
TABLE 47 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 122
TABLE 48 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 124
TABLE 49 KEY PLAYERS PROVIDING 12-LEAD ECG DEVICES 125
TABLE 50 12-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 126
TABLE 51 5-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 128
TABLE 52 3-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 130
TABLE 53 6-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 132
TABLE 54 SINGLE-LEAD ECG DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 134
TABLE 55 OTHER ECG LEAD DEVICES MARKET, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 135
TABLE 56 DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 137
TABLE 57 KEY PLAYERS PROVIDING PORTABLE ECG DEVICES 138
TABLE 58 DIAGNOSTIC ECG DEVICES MARKET FOR PORTABLE ECG DEVICES,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 139
TABLE 59 KEY PLAYERS PROVIDING WEARABLE DIAGNOSTIC ECG DEVICES 140
TABLE 60 DIAGNOSTIC ECG DEVICES MARKET FOR WEARABLE ECG DEVICES,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 141
TABLE 61 DIAGNOSTIC ECG DEVICES MARKET FOR IMPLANTABLE ECG DEVICES,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 143
TABLE 62 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY,
2023–2032 (USD MILLION) 145
TABLE 63 DIAGNOSTIC ECG DEVICES MARKET FOR STANDALONE ECG,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 146
TABLE 64 DIAGNOSTIC ECG DEVICES MARKET FOR PC-BASED ECG DEVICES,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 148
TABLE 65 DIAGNOSTIC ECG DEVICES MARKET FOR CLOUD-BASED ECG DEVICES,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 150
TABLE 66 DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 152
TABLE 67 DIAGNOSTIC ECG MARKET FOR HOSPITALS, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 153
TABLE 68 DIAGNOSTIC ECG MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 155
TABLE 69 DIAGNOSTIC ECG MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 157
TABLE 70 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS,
BY COUNTRY/REGION, 2023–2032 (USD MILLION) 159
TABLE 71 DIAGNOSTIC ECG MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 161
TABLE 72 DIAGNOSTIC ECG MARKET FOR URGENT CARE SETTINGS, BY COUNTRY/REGION, 2023–2032 (USD MILLION) 163
TABLE 73 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY COUNTRY/REGION,
2023–2032 (USD MILLION) 165
TABLE 74 DIAGNOSTIC ECG MARKET, BY REGION, 2023–2032 (USD MILLION) 168
TABLE 75 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 169
TABLE 76 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 170
TABLE 77 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 170
TABLE 78 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 171
TABLE 79 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 171
TABLE 80 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 172
TABLE 81 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 172
TABLE 82 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 173
TABLE 83 US: KEY MACROINDICATORS 174
TABLE 84 US: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 174
TABLE 85 US: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 174
TABLE 86 US: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 175
TABLE 87 US: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 175
TABLE 88 US: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 176
TABLE 89 US: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 176
TABLE 90 CANADA: KEY MACROINDICATORS 177
TABLE 91 CANADA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 177
TABLE 92 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 178
TABLE 93 CANADA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 178
TABLE 94 CANADA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 179
TABLE 95 CANADA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 179
TABLE 96 CANADA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 180
TABLE 97 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2023–2032 (USD MILLION) 181
TABLE 98 EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 181
TABLE 99 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 182
TABLE 100 EUROPE: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE,
2023–2032 (THOUSAND UNITS) 182
TABLE 101 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 183
TABLE 102 EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 183
TABLE 103 EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 184
TABLE 104 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 184
TABLE 105 GERMANY: KEY MACROINDICATORS 185
TABLE 106 GERMANY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 185
TABLE 107 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 186
TABLE 108 GERMANY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 186
TABLE 109 GERMANY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 187
TABLE 110 GERMANY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 187
TABLE 111 GERMANY: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 188
TABLE 112 FRANCE: KEY MACROINDICATORS 188
TABLE 113 FRANCE: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 189
TABLE 114 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 189
TABLE 115 FRANCE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 190
TABLE 116 FRANCE: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 190
TABLE 117 FRANCE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 190
TABLE 118 FRANCE: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 191
TABLE 119 UK: KEY MACROINDICATORS 191
TABLE 120 UK: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 192
TABLE 121 UK: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 192
TABLE 122 UK: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 193
TABLE 123 UK: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 193
TABLE 124 UK: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 194
TABLE 125 UK: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 194
TABLE 126 ITALY: KEY MACROINDICATORS 195
TABLE 127 ITALY: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 195
TABLE 128 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 196
TABLE 129 ITALY: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 196
TABLE 130 ITALY: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 197
TABLE 131 ITALY: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 197
TABLE 132 ITALY: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 198
TABLE 133 SPAIN: KEY MACROINDICATORS 199
TABLE 134 SPAIN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 199
TABLE 135 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 199
TABLE 136 SPAIN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 200
TABLE 137 SPAIN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 200
TABLE 138 SPAIN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 201
TABLE 139 SPAIN: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 201
TABLE 140 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 202
TABLE 141 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 202
TABLE 142 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 203
TABLE 143 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 203
TABLE 144 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 204
TABLE 145 REST OF EUROPE: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 204
TABLE 146 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 207
TABLE 147 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 207
TABLE 148 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 208
TABLE 149 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 208
TABLE 150 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 209
TABLE 151 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 209
TABLE 152 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 210
TABLE 153 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 210
TABLE 154 JAPAN: MACROECONOMIC INDICATORS 211
TABLE 155 JAPAN: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 211
TABLE 156 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 212
TABLE 157 JAPAN: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 212
TABLE 158 JAPAN: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 213
TABLE 159 JAPAN: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 213
TABLE 160 JAPAN: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 214
TABLE 161 CHINA: MACROECONOMIC INDICATORS 215
TABLE 162 CHINA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 215
TABLE 163 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 215
TABLE 164 CHINA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 216
TABLE 165 CHINA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 216
TABLE 166 CHINA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 217
TABLE 167 CHINA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 217
TABLE 168 INDIA: MACROECONOMIC INDICATORS 218
TABLE 169 INDIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 218
TABLE 170 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 219
TABLE 171 INDIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 219
TABLE 172 INDIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 220
TABLE 173 INDIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 220
TABLE 174 INDIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 221
TABLE 175 AUSTRALIA: KEY MACROINDICATORS 221
TABLE 176 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 222
TABLE 177 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 222
TABLE 178 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 223
TABLE 179 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 223
TABLE 180 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 223
TABLE 181 AUSTRALIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 224
TABLE 182 SOUTH KOREA: MACROECONOMIC INDICATORS 225
TABLE 183 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 225
TABLE 184 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 225
TABLE 185 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 226
TABLE 186 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 226
TABLE 187 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 226
TABLE 188 SOUTH KOREA: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 227
TABLE 189 MALAYSIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 228
TABLE 190 MALAYSIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 228
TABLE 191 MALAYSIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 229
TABLE 192 MALAYSIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 229
TABLE 193 MALAYSIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 229
TABLE 194 MALAYSIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 230
TABLE 195 THAILAND: MACROECONOMIC INDICATORS 231
TABLE 196 THAILAND: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 231
TABLE 197 THAILAND: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 231
TABLE 198 THAILAND: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 232
TABLE 199 THAILAND: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 232
TABLE 200 THAILAND: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 232
TABLE 201 THAILAND: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 233
TABLE 202 INDONESIA: MACROECONOMIC INDICATORS 234
TABLE 203 INDONESIA: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 234
TABLE 204 INDONESIA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 234
TABLE 205 INDONESIA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 235
TABLE 206 INDONESIA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 235
TABLE 207 INDONESIA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 235
TABLE 208 INDONESIA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 236
TABLE 209 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 237
TABLE 210 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 237
TABLE 211 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 238
TABLE 212 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 238
TABLE 213 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 239
TABLE 214 REST OF ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 239
TABLE 215 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 240
TABLE 216 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 240
TABLE 217 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 241
TABLE 218 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET VOLUME, BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 241
TABLE 219 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 242
TABLE 220 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 242
TABLE 221 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 242
TABLE 222 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 243
TABLE 223 BRAZIL: MACROECONOMIC INDICATORS 244
TABLE 224 BRAZIL: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 244
TABLE 225 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 244
TABLE 226 BRAZIL: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 245
TABLE 227 BRAZIL: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 245
TABLE 228 BRAZIL: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 245
TABLE 229 BRAZIL: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 246
TABLE 230 MEXICO: MACROECONOMIC INDICATORS 247
TABLE 231 MEXICO: DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 247
TABLE 232 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 247
TABLE 233 MEXICO: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 248
TABLE 234 MEXICO: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 248
TABLE 235 MEXICO: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT,
2023–2032 (USD MILLION) 248
TABLE 236 MEXICO: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 249
TABLE 237 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 249
TABLE 238 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 250
TABLE 239 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 250
TABLE 240 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 251
TABLE 241 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 251
TABLE 242 REST OF LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 252
TABLE 243 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 253
TABLE 244 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 253
TABLE 245 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 254
TABLE 246 MIDDLE EAST AND AFRICA : DIAGNOSTIC ECG DEVICES MARKET VOLUME,
BY DEVICE TYPE, 2023–2032 (THOUSAND UNITS) 254
TABLE 247 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 255
TABLE 248 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 255
TABLE 249 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 256
TABLE 250 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 256
TABLE 251 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY COUNTRY,
2023–2032 (USD MILLION) 257
TABLE 252 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 257
TABLE 253 GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE,
2023–2032 (USD MILLION) 258
TABLE 254 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 258
TABLE 255 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE, 2023–2032 (USD MILLION) 259
TABLE 256 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 259
TABLE 257 GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 260
TABLE 258 KSA: KEY MACROINDICATORS 260
TABLE 259 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023–2032 (USD MILLION) 261
TABLE 260 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG DEVICES MARKET,
BY DEVICE TYPE, 2023–2032 (USD MILLION) 261
TABLE 261 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 262
TABLE 262 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 262
TABLE 263 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET,
BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 263
TABLE 264 KINGDOM OF SAUDI ARABIA (KSA): DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 263
TABLE 265 UAE: KEY MACROINDICATORS 264
TABLE 266 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 264
TABLE 267 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG DEVICES MARKET,
BY DEVICE TYPE, 2023–2032 (USD MILLION) 265
TABLE 268 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 265
TABLE 269 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 266
TABLE 270 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET,
BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 266
TABLE 271 UNITED ARAB EMIRATES (UAE): DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 267
TABLE 272 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 268
TABLE 273 REST OF GCC COUNTRIES: DIAGNOSTIC ECG DEVICES MARKET, BY DEVICE TYPE, 2023–2032 (USD MILLION) 268
TABLE 274 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,
2023–2032 (USD MILLION) 269
TABLE 275 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 269
TABLE 276 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 270
TABLE 277 REST OF GCC COUNTRIES: DIAGNOSTIC ECG MARKET, BY END USER,
2023–2032 (USD MILLION) 270
TABLE 278 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY PRODUCT,
2023–2032 (USD MILLION) 271
TABLE 279 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET,
BY DEVICE TYPE, 2023–2032 (USD MILLION) 271
TABLE 280 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023–2032 (USD MILLION) 272
TABLE 281 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY TYPE,
2023–2032 (USD MILLION) 272
TABLE 282 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY CONNECTIVITY/DEPLOYMENT, 2023–2032 (USD MILLION) 273
TABLE 283 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2023–2032 (USD MILLION) 273
TABLE 284 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
DIAGNOSTIC ECG MARKET 274
TABLE 285 DIAGNOSTIC ECG MARKET: DEGREE OF COMPETITION, 2024 278
TABLE 286 DIAGNOSTIC ECG MARKET: REGION FOOTPRINT 283
TABLE 287 DIAGNOSTIC ECG MARKET: PRODUCT FOOTPRINT 284
TABLE 288 DIAGNOSTIC ECG MARKET: LEAD TYPE FOOTPRINT 285
TABLE 289 DIAGNOSTIC ECG MARKET: TYPE FOOTPRINT 286
TABLE 290 DIAGNOSTIC ECG MARKET: DEPLOYMENT/CONNECTIVITY FOOTPRINT 287
TABLE 291 DIAGNOSTIC ECG MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 289
TABLE 292 DIAGNOSTIC ECG MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS 290
TABLE 293 DIAGNOSTIC ECG MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–MARCH 2025 293
TABLE 294 DIAGNOSTIC ECG MARKET: DEALS, JANUARY 2022–MARCH 2025 295
TABLE 295 DIAGNOSTIC ECG MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025 297
TABLE 296 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–MARCH 2025 298
TABLE 297 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 300
TABLE 298 KONINKLIJKE PHILIPS N. V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 301
TABLE 299 KONINKLIJKE PHILIPS N. V.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2022–APRIL 2025 303
TABLE 300 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2022–APRIL 2025 304
TABLE 301 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 304
TABLE 302 GE HEALTHCARE: COMPANY OVERVIEW 306
TABLE 303 GE HEALTHCARE: PRODUCTS OFFERED 307
TABLE 304 GE HEALTHCARE: DEALS, JANUARY 2022–APRIL 2025 308
TABLE 305 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 309
TABLE 306 MEDTRONIC: COMPANY OVERVIEW 311
TABLE 307 MEDTRONIC: PRODUCTS OFFERED 312
TABLE 308 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 314
TABLE 309 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 316
TABLE 310 ABBOTT LABORATORIES: COMPANY OVERVIEW 317
TABLE 311 ABBOTT: PRODUCTS OFFERED 318
TABLE 312 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 319
TABLE 313 BAXTER: COMPANY OVERVIEW 320
TABLE 314 BAXTER: PRODUCTS OFFERED 321
TABLE 315 FUKUDA DENSHI: COMPANY OVERVIEW 325
TABLE 316 FUKUDA DENSHI: PRODUCTS OFFERED 326
TABLE 317 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 328
TABLE 318 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 329
TABLE 319 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 331
TABLE 320 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 332
TABLE 321 OSI SYSTEMS, INC: COMPANY OVERVIEW 334
TABLE 322 OSI SYSTEMS, INC.: PRODUCTS OFFERED 335
TABLE 323 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2022–APRIL 2025 336
TABLE 324 BITTIUM: COMPANY OVERVIEW 337
TABLE 325 BITTIUM: PRODUCTS OFFERED 338
TABLE 326 BITTIUM: DEALS, JANUARY 2022–APRIL 2025 339
TABLE 327 IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW 340
TABLE 328 IRHYTHM TECHNOLOGIES, INC.: PRODUCTS OFFERED 341
TABLE 329 IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–APRIL 2025 341
TABLE 330 IRHYTHM TECHNOLOGIES, INC.: DEALS, JANUARY 2022–APRIL 2025 342
TABLE 331 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 343
TABLE 332 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 344
TABLE 333 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES
AND APPROVALS, JANUARY 2022–APRIL 2025 345
TABLE 334 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 346
TABLE 335 MIDMARK CORPORATION: COMPANY OVERVIEW 347
TABLE 336 MIDMARK CORPORATION: PRODUCTS OFFERED 347
TABLE 337 MIDMARK CORPORATION: PRODUCT LAUNCH, JANUARY 2022–APRIL 2025 348
TABLE 338 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 349
TABLE 339 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 349
TABLE 340 BPL MEDICAL TECHNOLOGIES: EXPANSIONS, JANUARY 2022–APRIL 2025 350
TABLE 341 BPL MEDICAL TECHNOLOGIES: OTHER DEVELOPMENTS,
JANUARY 2022–APRIL 2025 351
TABLE 342 SCHILLER: COMPANY OVERVIEW 352
TABLE 343 SCHILLER: PRODUCTS OFFERED 352
TABLE 344 SCHILLER: PRODUCT LAUNCH, JANUARY 2022–APRIL 2025 353
TABLE 345 SCHILLER: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 353
TABLE 346 ACS DIAGNOSTICS: COMPANY OVERVIEW 354
TABLE 347 ACS DIAGNOSTICS: PRODUCTS OFFERED 354
TABLE 348 ALLENGERS: COMPANY OVERVIEW 355
TABLE 349 ALLENGERS: PRODUCTS OFFERED 355
TABLE 350 BIONET CO., LTD.: COMPANY OVERVIEW 356
TABLE 351 BIONET CO., LTD.: PRODUCTS OFFERED 356
TABLE 352 BIONET CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 357
LIST OF FIGURES
FIGURE 1 DIAGNOSTIC ECG MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 31
FIGURE 2 DIAGNOSTIC ECG MARKET: YEARS CONSIDERED 33
FIGURE 3 DIAGNOSTIC ECG MARKET: RESEARCH DESIGN 35
FIGURE 4 DIAGNOSTIC ECG MARKET: KEY PRIMARY SOURCES 38
FIGURE 5 DIAGNOSTIC ECG MARKET: INSIGHTS FROM PRIMARIES 39
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 39
FIGURE 7 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 8 DIAGNOSTIC ECG MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2024) 40
FIGURE 9 DIAGNOSTIC ECG: MARKET SIZE ESTIMATION 41
FIGURE 10 TOP-DOWN APPROACH 42
FIGURE 11 BOTTOM-UP APPROACH 43
FIGURE 12 DATA TRIANGULATION METHODOLOGY 45
FIGURE 13 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2025 VS. 2032 (USD MILLION) 48
FIGURE 14 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2025 VS. 2032 (USD MILLION) 49
FIGURE 15 DIAGNOSTIC ECG MARKET, BY TYPE, 2025 VS. 2032 (USD MILLION) 49
FIGURE 16 DIAGNOSTIC ECG MARKET, BY DEPLOYMENT/CONNECTIVITY,
2025 VS. 2032 (USD MILLION) 50
FIGURE 17 DIAGNOSTIC ECG MARKET, BY END USER, 2025 VS. 2032 (USD MILLION) 50
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET 51
FIGURE 19 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES GLOBALLY TO
DRIVE MARKET GROWTH 52
FIGURE 20 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2024 53
FIGURE 21 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC
ECG DEVICES MARKET IN 2025 53
FIGURE 22 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2032 54
FIGURE 23 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE
MARKET IN 2032 55
FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET
FROM 2025 TO 2032 56
FIGURE 25 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 57
FIGURE 26 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 67
FIGURE 27 DIAGNOSTIC ECG MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025) 74
FIGURE 28 TOP APPLICANT COUNTRIES/REGIONS FOR DIAGNOSTIC ECG PATENTS
(JANUARY 2014–MAY 2025) 75
FIGURE 29 AVERAGE SELLING PRICE FOR RESTING ECG, BY KEY PLAYER, 2024 78
FIGURE 30 AVERAGE SELLING PRICE FOR STRESS ECG, BY KEY PLAYER, 2024 78
FIGURE 31 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2024 79
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
DIAGNOSTIC ECG PRODUCTS 82
FIGURE 33 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 83
FIGURE 34 DIAGNOSTIC ECG MARKET: VALUE CHAIN ANALYSIS 85
FIGURE 35 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS 87
FIGURE 36 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS 89
FIGURE 37 AI USE CASES 91
FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
FIGURE 39 DIAGNOSTIC ECG MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024 102
FIGURE 40 DIAGNOSTIC ECG MARKET: GEOGRAPHIC SNAPSHOT 167
FIGURE 41 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT 169
FIGURE 42 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT 206
FIGURE 43 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN DIAGNOSTIC
ECG MARKET (2022–2024) 277
FIGURE 44 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, 2024 278
FIGURE 45 RANKING OF KEY PLAYERS IN DIAGNOSTIC ECG MARKET, 2024 280
FIGURE 46 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 281
FIGURE 47 DIAGNOSTIC ECG MARKET: COMPANY FOOTPRINT 282
FIGURE 48 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 288
FIGURE 49 DIAGNOSTIC ECG MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 291
FIGURE 50 EV/EBITDA OF KEY VENDORS 292
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 292
FIGURE 52 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT, 2024 301
FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT, 2024 307
FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2024) 312
FIGURE 55 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 315
FIGURE 56 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 318
FIGURE 57 BAXTER: COMPANY SNAPSHOT, 2024 321
FIGURE 58 FUKUDA DENSHI: COMPANY SNAPSHOT, 2024 326
FIGURE 59 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT, 2024 329
FIGURE 60 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT, 2024 332
FIGURE 61 OSI SYSTEMS, INC.: COMPANY SNAPSHOT, 2024 335
FIGURE 62 BITTIUM: COMPANY SNAPSHOT, 2024 338
FIGURE 63 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT, 2024 340
FIGURE 64 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT, 2024 344
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11